NCT03143712

Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet

An Open Label Study to Compare the Oral Bioavailability of a Tablet of GLPG1690 Relative to a Capsule After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Tablet

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Galapagos NV · Industry
• Sex: Male
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study is a Phase I, randomized, open-label, cross-over study with three single-dose treatments to compare the bioavailability of an oral tablet relative to an oral capsule of GLPG1690 after single dose intake in healthy male subjects and to evaluate the effect of food on the bioavailability of the oral tablet.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	GLPG1690	Oral administration of GLPG1690 in three different treatment conditions (treatment A through C)

Timeline

• Start date: 2017-04-18
• Primary completion: 2017-06-14
• Completion: 2017-06-14
• First posted: 2017-05-08
• Last updated: 2017-06-20

Locations

1 site across 1 country: Belgium